Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
PLoS Negl Trop Dis ; 12(4): e0006443, 2018 04.
Artigo em Inglês | MEDLINE | ID: mdl-29694346

RESUMO

Dengue virus (DENV) is the most prevalent and burdensome arbovirus transmitted by Aedes mosquitoes, against which there is only a limited licensed vaccine and no approved drug treatment. A Chromobacterium species, C. sp. Panama, isolated from the midgut of A. aegypti is able to inhibit DENV replication within the mosquito and in vitro. Here we show that C. sp. Panama mediates its anti-DENV activity through secreted factors that are proteinous in nature. The inhibitory effect occurs prior to virus attachment to cells, and is attributed to a factor that destabilizes the virion by promoting the degradation of the viral envelope protein. Bioassay-guided fractionation, coupled with mass spectrometry, allowed for the identification of a C. sp. Panama-secreted neutral protease and an aminopeptidase that are co-expressed and appear to act synergistically to degrade the viral envelope (E) protein and thus prevent viral attachment and subsequent infection of cells. This is the first study characterizing the anti-DENV activity of a common soil and mosquito-associated bacterium, thereby contributing towards understanding how such bacteria may limit disease transmission, and providing new tools for dengue prevention and therapeutics.


Assuntos
Aminopeptidases/farmacologia , Antivirais/farmacologia , Chromobacterium/enzimologia , Vírus da Dengue/efeitos dos fármacos , Dengue/tratamento farmacológico , Proteínas do Envelope Viral/metabolismo , Proteínas de Bactérias/farmacologia , Dengue/virologia , Vírus da Dengue/fisiologia , Sistema Digestório/virologia , Proteólise , Vírion/efeitos dos fármacos , Ligação Viral/efeitos dos fármacos
2.
Sci Rep ; 7(1): 10684, 2017 09 06.
Artigo em Inglês | MEDLINE | ID: mdl-28878230

RESUMO

The aminopeptidase gene from Mesorhizobium SEMIA3007 was cloned and overexpressed in Escherichia coli. The enzyme called MesoAmp exhibited optimum activity at pH 8.5 and 45 °C and was strongly activated by Co2+ and Mn2+. Under these reaction conditions, the enzyme displayed Km and kcat values of 0.2364 ± 0.018 mM and 712.1 ± 88.12 s-1, respectively. Additionally, the enzyme showed remarkable stability in organic solvents and was active at high concentrations of NaCl, suggesting that the enzyme might be suitable for use in biotechnology. MesoAmp is responsible for 40% of the organism's aminopeptidase activity. However, the enzyme's absence does not affect bacterial growth in synthetic broth, although it interfered with biofilm synthesis and osmoregulation. To the best of our knowledge, this report describes the first detailed characterization of aminopeptidase from Mesorhizobium and suggests its importance in biofilm formation and osmotic stress tolerance. In summary, this work lays the foundation for potential biotechnological applications and/or the development of environmentally friendly technologies and describes the first solvent- and halo-tolerant aminopeptidases identified from the Mesorhizobium genus and its importance in bacterial metabolism.


Assuntos
Aminopeptidases/química , Aminopeptidases/farmacologia , Biofilmes/efeitos dos fármacos , Mesorhizobium/metabolismo , Sequência de Aminoácidos , Aminopeptidases/genética , Aminopeptidases/metabolismo , Ativação Enzimática , Evolução Molecular , Genoma Bacteriano , Genômica/métodos , Multimerização Proteica , Relação Quantitativa Estrutura-Atividade , Proteínas Recombinantes/química , Proteínas Recombinantes/genética , Análise de Sequência de DNA , Soluções
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA